A rapid label-free method for quantitation of human immunodeficiency virus type-1 particles by nanospectroscopy

Journal of Virological Methods

Volumn 182, Issue 1-2, 2012, Pages 70-75

  Block, Olivia ^a   Mitra, Anirban ^c   Novotny, Lukas ^b,c   Dykes, Carrie ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c Department of Physics and Astronomy ^*  (United States)

Author keywords

HIV 1; Nanospectroscopy; Virus particles

Indexed keywords

CAPSID PROTEIN; NUCLEIC ACID;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NANOANALYSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPECTROSCOPY; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CONCENTRATION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS MUTANT; VIRUS PARTICLE; VIRUS TITRATION;

HIV-1; HUMANS; NANOTECHNOLOGY; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS; TIME FACTORS; VIRAL LOAD; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84859981848     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.03.012     Document Type: Article

References (28)

1. Bennett A.E., Narayan K., Shi D., Hartnell L.M., Gousset K., He H., Lowekamp B.C., Yoo T.S., Bliss D., Freed E.O., Subramaniam S. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog. 2009, 5:e1000591.
2. Bhatta D., Michel A.A., Marti Villalba M., Emmerson G.D., Sparrow I.J., Perkins E.A., McDonnell M.B., Ely R.W., Cartwright G.A. Optical microchip array biosensor for multiplexed detection of bio-hazardous agents. Biosens. Bioelectron. 2011, 30:78-86.
3. Bourinbaiar A.S. The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol. 1994, 38:59-61.
4. Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res. 2010, 85:1-18.
5. Chen S.H., Lin K.I., Tang C.Y., Peng S.L., Chuang Y.C., Lin Y.R., Wang J.P., Lin C.S. Optical detection of human papillomavirus type 16 and type 18 by sequence sandwich hybridization with oligonucleotide-functionalized Au nanoparticles. IEEE Trans. Nanobiosci. 2009, 8:120-131.
6. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 2000, 74:8358-8367.
7. Dimitrov D.S., Willey R.L., Sato H., Chang L.J., Blumenthal R., Martin M.A. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 1993, 67:2182-2190.
8. Driskell J.D., Jones C.A., Tompkins S.M., Tripp R.A. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. Analyst 2011, 136:3083-3090.
9. Dykes C., Fox K., Lloyd A., Chiulli M., Morse E., Demeter L.M. Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants. Virology 2001, 285:193-203.
10. Dykes C., Wang J., Jin X., Planelles V., An D.S., Tallo A., Huang Y., Wu H., Demeter L.M. Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture. J. Clin. Microbiol. 2006, 44:1930-1943.
11. Eckstein D.A., Penn M.L., Korin Y.D., Scripture-Adams D.D., Zack J.A., Kreisberg J.F., Roederer M., Sherman M.P., Chin P.S., Goldsmith M.A. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 2001, 15:671-682.
12. Freed E.O. The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol. 2003, 11:56-59.
13. Gottlinger H.G., Dorfman T., Sodroski J.G., Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:3195-3199.
14. Higgins J.R., Pedersen N.C., Carlson J.R. Detection and differentiation by sandwich enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus- and acquired immunodeficiency syndrome-associated retroviruslike clinical isolates. J. Clin. Microbiol. 1986, 24:424-430.
15. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995, 69:6810-6818.
16. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 1992, 66:2232-2239.
17. Leutenegger C.M., Higgins J., Matthews T.B., Tarantal A.F., Luciw P.A., Pedersen N.C., North T.W. Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res. Hum. Retroviruses 2001, 17:243-251.
18. Lu T., Lee H., Chen T., Herchak S., Kim J.H., Fraser S.E., Flagan R.C., Vahala K. High sensitivity nanoparticle detection using optical microcavities. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5976-5979.
19. Mahalingam B., Louis J.M., Reed C.C., Adomat J.M., Krouse J., Wang Y.F., Harrison R.W., Weber I.T. Structural and kinetic analysis of drug resistant mutants of HIV-1 protease. Eur. J. Biochem. 1999, 263:238-245.
20. Mitra A., Deutsch B., Ignatovich F., Dykes C., Novotny L. Nano-optofluidic detection of single viruses and nanoparticles. ACS Nano 2010, 4:1305-1312.
21. Niikura K., Nagakawa K., Ohtake N., Suzuki T., Matsuo Y., Sawa H., Ijiro K. Gold nanoparticle arrangement on viral particles through carbohydrate recognition: a non-cross-linking approach to optical virus detection. Bioconjug. Chem. 2009, 20:1848-1852.
22. O'Connell K.A., Rabi S.A., Siliciano R.F., Blankson J.N. CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E689-E698.
23. Oster G. Two-phase formation in solutions of tobacco mosaic virus and the problem of long-range forces. J. Gen. Physiol. 1950, 33:445-473.
24. Piekna-Przybylska D., Dykes C., Demeter L.M., Bambara R.A. Sequences in the U3 region of human immunodeficiency virus 1 improve efficiency of minus strand transfer in infected cells. Virology 2011, 410:368-374.
25. Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., Pomerantz R.J. The challenge of finding a cure for HIV infection. Science 2009, 323:1304-1307.
26. Sarngadharan M.G., Popovic M., Bruch L., Schupbach J., Gallo R.C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984, 224:506-508.
27. Takasaki T., Kurane I., Aihara H., Ohkawa N., Yamaguchi J. Electron microscopic study of human immunodeficiency virus type 1 (HIV-1) core structure: two RNA strands in the core of mature and budding particles. Arch. Virol. 1997, 142:375-382.
28. Taylor N., Schmid I., Egle A., Greil R., Patsch W., Oberkofler H. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals. Antivir. Ther. 2009, 14:1189-1193.